These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 19606672)

  • 1. [Treatment and prophylaxis of alimentary tract lesions caused by non-steroid anti-inflammatory drugs].
    Gil J; Wojtuń S
    Pol Merkur Lekarski; 2009 May; 26(155):353-7. PubMed ID: 19606672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention.
    Lanas A; Ferrandez A
    Chin J Dig Dis; 2006; 7(3):127-33. PubMed ID: 16808792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
    Chan FK
    Chin J Dig Dis; 2005; 6(1):1-5. PubMed ID: 15667550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs.
    Jones R; Rubin G; Berenbaum F; Scheiman J
    Am J Med; 2008 Jun; 121(6):464-74. PubMed ID: 18501223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment.
    Lanas A; Scheiman J
    Curr Med Res Opin; 2007 Jan; 23(1):163-73. PubMed ID: 17257477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal bleeding associated with low-dose aspirin use: relevance and management in clinical practice.
    Lanas A
    Expert Opin Drug Saf; 2011 Jan; 10(1):45-54. PubMed ID: 20645883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
    Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
    Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of aspirin-induced gastroduodenal damage: H. pylori infection eradication versus proton pump inhibitors or both.
    Lanas A
    Dig Liver Dis; 2004 Oct; 36(10):655-7. PubMed ID: 15506662
    [No Abstract]   [Full Text] [Related]  

  • 9. [Complication of NSAIDs treatment in gastrointestinal tract].
    Wojtuń S; Gil J; Klupińska G; Chojnacki J
    Pol Merkur Lekarski; 2004; 17 Suppl 1():133-5. PubMed ID: 15603371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should we eradicate Helicobacter pylori in non-steroidal anti-inflammatory drug users?
    Sung JJ
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 2():65-70. PubMed ID: 15335415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prophylaxis and treatment of gastric ulcer by low-dose aspirin in the aged].
    Ueki N; Miyake K; Sakamoto C
    Nihon Rinsho; 2010 Nov; 68(11):2083-8. PubMed ID: 21061537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Update on current care guidelines. Safe use of non-steroidal anti-inflammatory drugs].
    Karvonen AL; Hakala M; Helin-Salmivaara A; Kankaanranta H; Kivilaakso E; Kunnamo I; Lehtola J; Martio J
    Duodecim; 2009; 125(5):563-4. PubMed ID: 19385345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in peptic ulcer between the East and the West.
    Leong RW
    Gastroenterol Clin North Am; 2009 Jun; 38(2):363-79. PubMed ID: 19446264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disadvantageous effects of nonsteroidal anti-inflammatory drugs on the alimentary tract.
    Cichoz-Lach H; Celiński K
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):403-8. PubMed ID: 12898870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risks of severe digestive adverse effects of NSAIDs. Evaluation methods of mucoprotective drugs].
    Delchier JC; Belda E
    Rev Rhum Ed Fr; 1993 Jul; 60(6 Pt 2):87S-89S. PubMed ID: 8118458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providers.
    Elnachef N; Scheiman JM; Fendrick AM; Howden CW; Chey WD
    Aliment Pharmacol Ther; 2008 Nov; 28(10):1249-58. PubMed ID: 18729848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peptic diseases].
    Vouillamoz D; Viani F; Jornod P; Kessler V; Ehmann T; Dorta G
    Rev Med Suisse; 2005 Jan; 1(3):200-2, 205-8. PubMed ID: 15770814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of use of proton pump inhibitors in Greece.
    Ntaios G; Chatzinikolaou A; Kaiafa G; Savopoulos C; Hatzitolios A; Karamitsos D
    Eur J Intern Med; 2009 Mar; 20(2):171-3. PubMed ID: 19327607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The appropriate use of proton-pump inhibitor co-therapy with non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors.
    Lanas A
    Aliment Pharmacol Ther; 2005 Mar; 21 Suppl 1():2-4, 21-4. PubMed ID: 15755265
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-steroidal anti-inflammatory drugs have bacteriostatic and bactericidal activity against Helicobacter pylori.
    Shirin H; Moss SF; Kancherla S; Kancherla K; Holt PR; Weinstein IB; Sordillo EM
    J Gastroenterol Hepatol; 2006 Sep; 21(9):1388-93. PubMed ID: 16911681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.